The claim construction is mixed but slightly favorable to Treace on the core 'bone positioning guide' term. The case continues toward summary judgment or trial on infringement. Monitor for summary judgment motions and the court's resolution of the deferred indefiniteness challenges, which could narrow or invalidate claims.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+1- T+0 · Nov 13 $5.27entry
- T+1 · yesterday −16.13%α −14.22% · $4.42
- T+2 · todayOpen
- T+5 · in 2d Pending
- T+20 · in 26d Pending
- T+60 · in 3mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
The court issued a Markman claim construction ruling in Treace Medical's patent infringement suit against Stryker and Wright Medical. The court adopted Treace's proposed constructions for key terms including 'bone positioning guide' and 'guide surface' in the '849 patent, while adopting defendants' constructions for 'guide surface' in the '387 patent, 'bone engagement member,' 'tip,' and 'system.' The court deferred indefiniteness challenges on seven other terms. This is an interlocutory procedural ruling that does not resolve infringement or validity.
Court Ruling Details
Key Facts
- Court adopted Treace's construction of 'bone positioning guide' as 'a device specifically designed to regulate or direct the progressive motion of a bone being repositioned'
- Court adopted defendants' construction of 'guide surface' in the '387 patent as 'an enclosed surface of the bone preparation guide that abuts a tissue removing instrument to guide cutting of a bone'
- Court adopted Treace's construction of 'guide surface' and 'guiding surface' in the '849 patent as 'a portion of a bone preparation or cutting guide that regulates or directs the progressive motion of a tissue removing instrument and/or cutting tool'
- Court adopted defendants' alternative construction of 'bone engagement member' as 'part of the bone positioning guide capable of contacting a misaligned bone'
- Court adopted defendants' alternative construction of 'tip' as 'part of the bone positioning guide capable of contacting a bone distinct from a bone contacted by the bone engagement member'
- Court adopted its own construction of 'main body member' as 'the structural component that includes, carries, and/or supports the parts of the bone positioning guide used to contact and move bones'
- Court adopted Treace's construction of 'the bone positioning guide is fabricated from a radiolucent material' as 'constructed in part or whole from radiolucent material'
- Court adopted defendants' construction of 'system' as 'each device or component recited in the claim is a non-optional part of the system'
- Court deferred indefiniteness challenges on seven terms: 'anatomically aligned position,' 'anatomically misaligned position,' 'alignment...adjusting an alignment,' 'corrected alignment,' 'base,' 'leg,' and 'bridge'
Financial Impact
No damages or financial figures stated in the ruling. This is a claim construction order with no monetary award.
Risk Factors
- Seven claim terms remain unresolved with indefiniteness challenges pending, which could invalidate claims if defendants prevail
- The court adopted defendants' narrower construction of 'guide surface' in the '387 patent, which may limit Treace's infringement case on that patent
- The antitrust claims against Stryker were dismissed three times and remain dismissed
- Document contains text addressed to automated readers
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 court opinion.
| Document | Accession Number |
|---|---|
| COURT-RULING Data (Synthetic) | court-022d374c0d-TMCI |
Track record
11 reports on TMCI
2 of 3 bullish or bearish reports moved the stock their way by T+1. Best: +12.39% at T+60 after the Jul 13, 2026 report. 2 of 3 went positive at some point.
Filters
- Nov 16, 20261d ago SC 13G Neutral 4/10 Entry $4.42 to $4.44 Now $4.44 +0.45% ▲ +0.45% +1.47% vs SPY
- Nov 16, 20261d ago SC 13G/A Bearish 4/10 Entry $4.42 to $4.44 Now $4.44 −0.45% ▼ −0.45% −1.47% vs SPY
- Nov 12, 20266d ago Court Ruling Neutral 4/10 Viewing Entry $5.27 to $4.42 Now $4.44 −15.75% ▼ −16.13% −14.22% vs SPY
- Nov 6, 202611d ago 8-K Neutral 4/10 Entry $4.03 to $4.78 Now $4.44 +10.17% ▲ +18.61% +16.24% vs SPY
- Sep 17, 20268w ago Press Release Neutral 4/10 Entry $4.49 to $4.48 Now $4.44 −1.11% ▼ −0.22% −1.77% vs SPY
- Aug 7, 202614w ago 8-K Mixed 6/10 Entry $4.76 to $4.67 Now $4.44 −6.72% ▼ −1.89% −1.86% vs SPY
- Jul 13, 202618w ago Court Ruling Bearish 5/10 Entry $4.44 to $4.40 Now $4.44 −0.00% ▲ +0.90% +1.30% vs SPY
- May 8, 202627w ago Press Release Bearish 7/10 Entry $2.01 to $1.94 Now $4.44 −120.90% ▲ +3.48% +3.71% vs SPY
- Apr 24, 202629w ago Press Release Neutral 1/10 Entry $1.98 to $1.92 Now $4.44 +124.24% ▼ −3.03% −3.19% vs SPY
- Apr 9, 202631w ago 8-K Mixed 6/10 Entry $1.53 to $1.81 Now $4.44 +190.20% ▲ +18.30% +18.36% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time Court Ruling Intelligence
Market-moving court rulings analyzed within minutes. Patent verdicts, antitrust decisions, class certifications, and more, parsed and scored by AI.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers